Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasm Metastasis 4Hematologic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms by Site 2Neoplasms by Histologic Type 2Melanoma 2Lymphoproliferative Disorders 2Leukemia, Myeloid, Acute 2Glioma 2Brain Neoplasms 2Uveal Melanoma 1Thrombocytosis 1Sarcoma 1Rare Tumour 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Noonan Syndrome 6 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Locally Advanced Thyroid Gland Carcinoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

vandetanib 1trametinib 1pralsetinib 1lenvatinib 1larotrectinib 1entrectinib 1donafenib 1dabrafenib 1cabozantinib 1apatinib 1anlotinib 1Sorafenib 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Locally Advanced Thyroid Gland Carcinoma × entrectinib × Clear all
NCT06482086 2024-12-05

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

West China Hospital

Phase 2 Recruiting
75 enrolled
Head & Neck

Locally Advanced Thyroid Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡